SENORES PHARMACEUTICALS
Back to Balance Sheet
|
SENORES PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹0.59 Cr | ₹-19 Cr | ₹-15 Cr | ₹2.10 Cr | ₹-0.45 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SENORES PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹0.59 Cr |
| Mar2025 | ₹-19 Cr |
| Mar2024 | ₹-15 Cr |
| Mar2023 | ₹2.10 Cr |
| Mar2022 | ₹-0.45 Cr |
How is Deferred Tax Assets / Liabilities of SENORES PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹0.59 Cr | Positive | |
| Mar2025 | ₹-19 Cr | Negative | |
| Mar2024 | ₹-15 Cr | Negative | |
| Mar2023 | ₹2.10 Cr | Positive | |
| Mar2022 | ₹-0.45 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SENORES PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SENORES PHARMACEUTICALS | ₹6,040.5 Cr | 7.1% | -2.5% | 72% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.9% | -5% | 3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,611.0 Cr | 3.6% | -1.4% | 37.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,182.0 Cr | 1.7% | -6.7% | 28% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | 2.8% | -3.9% | -17.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,926.0 Cr | 5.4% | 8.7% | 1.6% | Stock Analytics | |
SENORES PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SENORES PHARMACEUTICALS | 7.1% |
-2.5% |
72% |
| SENSEX | -0.3% |
-1.6% |
-12.3% |
You may also like the below Video Courses